SCHEMBL10537874

SCHEMBL10537874

[CH2][C@@H](C)CC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL56255 1.00
SCHEMBL82969 0.82
SCHEMBL17607587 0.82 TSHR (0.35)
SCHEMBL1484068 0.82 TSHR (0.35)
SCHEMBL4654375 0.82 TSHR (0.35)
SCHEMBL3246553 0.79 TSHR (0.33)
SCHEMBL28431395 0.77 TSHR (0.32)
SCHEMBL9215179 0.75
SCHEMBL3339089 0.75 TSHR (0.41)
SCHEMBL5984673 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4025300-A1 ATP-REGULATED POTASSIUM CHANNEL OPENERS COMPRISING GUANIDINE AND USES THEREOF Salzman Group Ltd. (IL) 2022-07-13 EP disclosed
WO-2021044413-A1 ATP-REGULATED POTASSIUM CHANNEL OPENERS COMPRISING GUANIDINE AND USES THEREOF SALZMAN GROUP LTD. (IL) 2021-03-11 WO disclosed
US-H645-H Process for the conversion of maleic acid derivatives to their corresponding fumaric isomers THE NUTRASWEET COMPANY (US) 1989-06-06 US disclosed